NAN vs TRJ

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

NAN

NANOSONICS FPO [NAN]

52MEDIUM

TRJ

TRAJAN GRO FPO [TRJ]

51MEDIUM

Score Breakdown

NAN TRJ
Technical
49
35
Catalyst
53
53
Sentiment
50
50
Fundamental
94
90
Momentum
41
31
Risk Gate
40
46

Key Metrics

NAN Metric TRJ
$965.5MMarket Cap$44.3M
440KAvg Volume (20d)256K
+6.9%Short InterestN/A
$4.77052-Week High$0.970
$2.96052-Week Low$0.190
-0.3%Daily Change-6.9%
$3.220Reference Price$0.270
+10.1%ROE-1.3%
+9.9%Profit Margin-0.8%

Active Signals

NAN Signals

MACD momentum is losing steam
Stochastic is deep in oversold territory — bounce conditions forming
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (4.7x)
Moderate revenue growth (+9%)
Piotroski F-Score strong (8/9, low-confidence approx)
EPS estimates revised upward (+3pts)

TRJ Signals

Trading below both moving averages — the trend is working against this one
Took a hit — down 12.9% over the last 5 days
Beating the Small Ords index — relative strength of 1.16, so it's outpacing the pack
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (0.3x)
EPS estimates revised upward (+10pts)
Near 52-week low (13% of range)

Ask Scout AI to compare NAN and TRJ in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

NEU vs PAR →NEU vs PHX →NEU vs PYC →NEU vs TRI →NOX vs PAR →
NAN Full Analysis → TRJ Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).